Eprosartan

CHEMBL813 Phase 4 Disetujui Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
424.5 g/mol
LogP
4.5
Phase
4

This medication blocks a receptor for angiotensin II, a hormone that constricts blood vessels, allowing vessels to relax and blood pressure to fall. It is used to treat high blood pressure and protect kidney function.

Berat Molekul

424,5000 g/mol

LogP

4,50

TPSA

121,00 Ų

Lipinski RO5

Lulus

Area Terapeutik

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Struktur 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CCCCc1ncc(/C=C(\Cc2cccs2)C(=O)O)n1Cc1ccc(C(=O)O)cc1

InChI

InChI=1S/C23H24N2O4S/c1-2-3-6-21-24-14-19(12-18(23(28)29)13-20-5-4-11-30-20)25(21)15-16-7-9-17(10-8-16)22(26)27/h4-5,7-12,14H,2-3,6,13,15H2,1H3,(H,26,27)(H,28,29)/b18-12+

Molecular Formula

C23H24N2O4S

HBD / HBA

2 / 6

Ikatan yang Dapat Dirotasi

10

Atom Berat

30

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Pertanyaan yang Sering Diajukan

This medication blocks a receptor for angiotensin II, a hormone that constricts blood vessels, allowing vessels to relax and blood pressure to fall. It is used to treat high blood pressure and protect kidney function.

Yes, Eprosartan is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL813. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 5281037. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Penyangkalan Medis

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.